Zoledronic acid (Zometa) - Oncology Nurse Advisor

Zoledronic acid (Zometa)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews zoledronic acid (Zometa), indicated for pain reduction associated with bone metastases, hypercalcemia of malignancy, and osteolytic lesions of multiple myeloma.

Next hm-slideshow in Slides